| Literature DB >> 31091445 |
Michaela Tencerova1, Morten Frost2, Florence Figeac3, Tina Kamilla Nielsen3, Dalia Ali3, Jens-Jacob Lindegaard Lauterlein3, Thomas Levin Andersen4, Anders Kristian Haakonsson5, Alexander Rauch3, Jonna Skov Madsen6, Charlotte Ejersted7, Kurt Højlund8, Moustapha Kassem9.
Abstract
Obesity is associated with increased risk for fragility fractures. However, the cellular mechanisms are unknown. Using a translational approach combining RNA sequencing and cellular analyses, we investigated bone marrow stromal stem cells (BM-MSCs) of 54 men divided into lean, overweight, and obese groups on the basis of BMI. Compared with BM-MSCs obtained from lean, obese BM-MSCs exhibited a shift of molecular phenotype toward committed adipocytic progenitors and increased expression of metabolic genes involved in glycolytic and oxidoreductase activity. Interestingly, compared with paired samples of peripheral adipose tissue-derived stromal cells (AT-MSCs), insulin signaling of obese BM-MSCs was enhanced and accompanied by increased abundance of insulin receptor positive (IR+) and leptin receptor positive (LEPR+) cells in BM-MSC cultures. Their hyper-activated metabolic state was accompanied by an accelerated senescence phenotype. Our data provide a plausible explanation for the bone fragility in obesity caused by enhanced insulin signaling leading to accelerated metabolic senescence of BM-MSCs.Entities:
Keywords: adipogenesis; adipose-derived stem cells; bone marrow skeletal stem cells; differentiation potential; insulin signaling; obesity; skeletal fragility
Mesh:
Year: 2019 PMID: 31091445 DOI: 10.1016/j.celrep.2019.04.066
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423